Cancer Research Cancer Epigenetics  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 1569-1577, April 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coons, S. W.
Right arrow Articles by Shapiro, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coons, S. W.
Right arrow Articles by Shapiro, J. R.

Cytogenetic and Flow Cytometry DNA Analysis of Regional Heterogeneity in a Low Grade Human Glioma1

Stephen W. Coons2, Peter C. Johnson and Joan Rankin Shapiro

Barrow Neurological Institute of St. Joseph's Hospital and Medical Center, Division of Neuropathology [S. W. C., P. C. J.] and Laboratory of Neuro-Oncology, Division of Neurology [J. R. S.], Phoenix, Arizona 85013-4496

This study combined flow cytometry with standard cytogenetic analysis of first division cells to evaluate regional heterogeneity in 38 spatially mapped regions of a low grade human oligoastrocytoma. Histologically, the tumor was relatively homogeneous. In contrast, flow cytometry and cytogenetic analyses identified variable percentages of near-diploid (ND; 35 to 57 chromosomes/metaphase) and near-tetraploid (81–103 chromosomes/metaphase) populations. The largest proportion of cells in the ND population was 46,XY with normal Giemsa bands; however, four karyotypically unrelated ND clones also were identified. The development of these clonal populations centered around a region in which more than 50% of the cells contained nonclonal abnormalities and which demonstrated more histological pleomorphism than any other region. The frequency of the nonclonal karyotypes suggested that this region was genetically unstable. Three of the clonal ND populations resided in small, spatially discreet areas of the tumor. The largest and the most widely distributed clonal population, 47,XY,+7, underwent further evolution to give rise to seven additional sidelines. This investigation demonstrates that low grade gliomas have areas of genetic instability capable of generating mutant cells with the capacity to proliferate and to form cellular foci. As a result, multiple, spatially distinct clonal populations can exist in low grade gliomas, some of which are capable of further cytogenetic evolution and clonal expansion, resulting in tumor progression.

1 Supported by CA50931 and CA25956.

2 To whom requests for reprints should be addressed, at Division of Neuropathology, Barrow Neurological Institute of St. Joseph's Hospital and Medical Center, 350 W. Thomas Road, Phoenix, AZ 85013-4496.

Received 9/14/94. Accepted 1/26/95.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Gao, K. Furge, J. Koeman, K. Dykema, Y. Su, M. L. Cutler, A. Werts, P. Haak, and G. F. Vande Woude
Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations
PNAS, May 22, 2007; 104(21): 8995 - 9000.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. Sanai, A. Alvarez-Buylla, and M. S. Berger
Neural Stem Cells and the Origin of Gliomas
N. Engl. J. Med., August 25, 2005; 353(8): 811 - 822.
[Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
J. M. Sayagues, M. D. Tabernero, A. Maillo, A. Espinosa, A. Rasillo, P. Diaz, J. Ciudad, A. Lopez, M. Merino, J. M. Goncalves, et al.
Intratumoral Patterns of Clonal Evolution in Meningiomas as Defined by Multicolor Interphase Fluorescence in Situ Hybridization (FISH): Is There a Relationship between Histopathologically Benign and Atypical/Anaplastic Lesions?
J. Mol. Diagn., November 1, 2004; 6(4): 316 - 325.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
W. K. Pfisterer, N. C. Hank, M. C. Preul, W. P. Hendricks, J. Pueschel, S. W. Coons, and A. C. Scheck
Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas
Neuro-oncol, October 1, 2004; 6(4): 290 - 299.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. C. Maley, B. J. Reid, and S. Forrest
Cancer Prevention Strategies That Address the Evolutionary Dynamics of Neoplastic Cells: Simulating Benign Cell Boosters and Selection for Chemosensitivity
Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1375 - 1384.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
A. Perry
Pathology of low-grade gliomas: An update of emerging concepts
Neuro-oncol, July 1, 2003; 5(3): 168 - 178.
[Abstract] [PDF]


Home page
NeurologyHome page
June 10 Highlights
Neurology, June 10, 2003; 60(11): 1729 - 1731.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Kanazawa, M. Ebina, N. Ino-oka, M. Shimizukawa, T. Takahashi, S. Fujimura, T. Imai, and T. Nukiwa
Transition from Squamous Cell Carcinoma to Adenocarcinoma in Adenosquamous Carcinoma of the Lung
Am. J. Pathol., April 1, 2000; 156(4): 1289 - 1298.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.